HF
BIVI icon

HRT Financial’s BioVie BIVI Stock Holding History

HRT Financial’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,482
Closed -$32K – 4225
2026
Q1 		$32K Buy
+23,482
New +$30.2K ﹤0.01% 3515
2025
Q2 		– Sell
-1,090
Closed -$10K – 2630
2025
Q1 		$10K Buy
+1,090
New +$17.4K ﹤0.01% 2352
2023
Q2 		– Sell
-172
Closed -$139K – 2483
2023
Q1 		$139K Buy
+172
New +$114K ﹤0.01% 1999
2022
Q4 		– Sell
-176
Closed -$43K – 2479
2022
Q3 		$43K Buy
+176
New +$41.9K ﹤0.01% 2452

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

HRT Financial's BIVI Position: Q2 2026 in Review

HRT Financial sold out of BioVie (BIVI) in Q2 2026, closing a stake of 23,482 shares — an estimated $32K sold.

HRT Financial first reported a position in BIVI in Q3 2022 and held it in 4 quarters. The position peaked at $139K in Q1 2023. 35 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • HRT Financial reported no remaining BioVie position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 23,482 BioVie shares in Q2 2026, an estimated $32K.
  • HRT Financial first reported a position in BioVie in Q3 2022 and held it in 4 quarters.
  • HRT Financial's BioVie position peaked at $139K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.